Showing 1 - 7 results of 7 for search 'Nicole J. Toney', query time: 0.04s Refine Results
  1. 1
    Phosphoflow cytometry to assess cytokine signaling pathways in peripheral immune cells: potential for inferring immune cell function and treatment response in patients with solid tumors

    Phosphoflow cytometry to assess cytokine signaling pathways in peripheral immune cells: potential for inferring immune cell function and treatment response in patients with solid t... by Nicole J. Toney, Jeffrey Schlom, Renee N. Donahue

    Published 2023-09-01
    Get full text
    Article
  2. 2
    Peripheral immune biomarkers for immune checkpoint inhibition of solid tumours

    Peripheral immune biomarkers for immune checkpoint inhibition of solid tumours by Meghali Goswami, Nicole J. Toney, Stephanie C. Pitts, Carolina Celades, Jeffrey Schlom, Renee N. Donahue

    Published 2024-08-01
    Get full text
    Article
  3. 3
    Early changes in immune cell subsets with corticosteroids in patients with solid tumors: implications for COVID-19 management

    Early changes in immune cell subsets with corticosteroids in patients with solid tumors: implications for COVID-19 management by Renee N Donahue, Jeffrey Schlom, James L Gulley, Lisa Cordes, Jennifer L Marté, Nicole J Toney

    Published 2020-10-01
    Get full text
    Article
  4. 4
    B cells enhance IL-1 beta driven invasiveness in triple negative breast cancer

    B cells enhance IL-1 beta driven invasiveness in triple negative breast cancer by Nicole J. Toney, Lynn M. Opdenaker, Lisa Frerichs, Shirin R. Modarai, Aihui Ma, Holly Archinal, Grace O. Ajayi, Jennifer Sims-Mourtada

    Published 2025-01-01
    Get full text
    Article
  5. 5
    1063 Immune correlates with response in patients with metastatic solid tumors treated with a tumor targeting immunocytokine NHS-IL12

    1063 Immune correlates with response in patients with metastatic solid tumors treated with a tumor targeting immunocytokine NHS-IL12 by Renee N Donahue, Jeffrey Schlom, James L Gulley, Julius Strauss, Margaret E Gatti-Mays, Nicole J Toney, Nicholas P Tschernia, Stephanie C Pitts

    Published 2023-11-01
    Article
  6. 6
    Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study

    Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study by Filipa Lynce, Candace Mainor, Renee N. Donahue, Xue Geng, Greg Jones, Ilana Schlam, Hongkun Wang, Nicole J. Toney, Caroline Jochems, Jeffrey Schlom, Jay Zeck, Christopher Gallagher, Rita Nanda, Deena Graham, Erica M. Stringer-Reasor, Neelima Denduluri, Julie Collins, Ami Chitalia, Shruti Tiwari, Raquel Nunes, Rebecca Kaltman, Katia Khoury, Margaret Gatti-Mays, Paolo Tarantino, Sara M. Tolaney, Sandra M. Swain, Paula Pohlmann, Heather A. Parsons, Claudine Isaacs

    Published 2024-03-01
    Get full text
    Article
  7. 7
    Author Correction: Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study

    Author Correction: Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study by Filipa Lynce, Candace Mainor, Renee N. Donahue, Xue Geng, Greg Jones, Ilana Schlam, Hongkun Wang, Nicole J. Toney, Caroline Jochems, Jeffrey Schlom, Jay Zeck, Christopher Gallagher, Rita Nanda, Deena Graham, Erica M. Stringer-Reasor, Neelima Denduluri, Julie Collins, Ami Chitalia, Shruti Tiwari, Raquel Nunes, Rebecca Kaltman, Katia Khoury, Margaret Gatti-Mays, Paolo Tarantino, Sara M. Tolaney, Sandra M. Swain, Paula Pohlmann, Heather A. Parsons, Claudine Isaacs

    Published 2024-05-01
    Get full text
    Article

Search Tools: